Literature DB >> 10498389

Von Willebrand factor in plasma of patients with advanced stages of larynx cancer.

R Paczuski1, A Bialkowska, M Kotschy, D Burduk, S Betlejewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10498389     DOI： 10.1016/s0049-3848(99)00041-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer.

Authors:  Ignasio Gil-Bazo; Ignacio Gil Bazo; Victoria Catalán Goni; Victoria Catalán González; Alvaro Alonso Gutiérrez; Javier Rodríguez Rodríguez; José Antonio Páramo Fernández; Juan de la Cámara Gómez; José Luis Hernández Lizoain; Jesús García-Foncillas López
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

2.  Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma.

Authors:  Wei-Shu Wang; Jen-Kou Lin; Tzu-Chen Lin; Tzeon-Jye Chiou; Jin-Hwang Liu; Chueh-Chuan Yen; Po-Min Chen
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin.

Authors:  P Jurasz; M W Stewart; A Radomski; F Khadour; M Duszyk; M W Radomski
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  The clinical value of von Willebrand factor in colorectal carcinomas.

Authors:  Vera S Schellerer; Larissa Mueller-Bergh; Susanne Merkel; Robert Zimmermann; Dominik Weiss; Anne Schlabrakowski; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Am J Transl Res       Date:  2011-09-23       Impact factor: 4.060

5.  Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma.

Authors:  Giovanni Marfia; Stefania Elena Navone; Claudia Fanizzi; Silvia Tabano; Chiara Pesenti; Loubna Abdel Hadi; Andrea Franzini; Manuela Caroli; Monica Miozzo; Laura Riboni; Paolo Rampini; Rolando Campanella
Journal:  Cancer Med       Date:  2016-05-28       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.